HomeAI · summaries
Storia in 3 fonti
Emcure subsidiary Gennova to transfer mRNA business to Immunoscript Life Science for ₹139 crore
Emcure's Gennova transfers its mRNA business to Immunoscript Life Science for ₹139 crore, focusing on core biotech operations.
Confronto fonti
3 prospettive sulla stessa storiaTimeline cronologica
- ·
thehindubusinessline.com
Emcure subsidiary Gennova to transfer mRNA business to Immunoscript Life Science for ₹139 crore
Emcure's Gennova transfers its mRNA business to Immunoscript Life Science for ₹139 crore, focusing on core biotech operations.
- ·
thehindu.com
Emcure to take full control of Gennova Biopharma with ₹232 crore stake acquisition
Emcure Pharmaceuticals acquires full control of Gennova Biopharma with a ₹232 crore stake purchase, enhancing its biologics focus.
- ·
economictimes.indiatimes.com
Emcure buys remaining 12.05% in Gennova to take full control
Emcure Pharma is acquiring the remaining stake in Gennova Biopharmaceuticals. This move simplifies ownership and sharpens strategic focus for the subsidiary. Gennova will now be…